Cabaletta Bio Inc (CABA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cabaletta Bio Inc   (NASDAQ: CABA)


Cabaletta Bio Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cabaletta Bio Inc's ROI in the second quarter of 2026?
Cabaletta Bio Inc recorded a cumulative net loss of $-181 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -124.53%.

Within the Healthcare sector 652 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3423 to 4132.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -10.89 % -18.15 % -24.74 % -26.76 % -20.52 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 217 107 115 144 183
Return On Investment (TTM) -124.53 % -127.92 % -117.16 % -102.92 % -88.3 %
CABA's Overall Ranking # 4132 # 3423 # 3388 # 2886 # 3529
Seq. Investment Change TTM 6.17 % -4.28 % -6.98 % -5.74 % -2.47 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -181 -175 -168 -159 -144

CABA Company Profile >> Back to CABA Roi Comparisons >> See Annual CABA Return On Investment



Return On Investment CABA's Ranking
Within: No.
Industry # 112
Sector # 653
Overall # 4132

Return On Investment Statistics
High Average Low
-10.95 %
-55.38 %
-127.92 %
(Sep 30 2019)   (Mar 31 2026)







Financial Statements
Cabaletta Bio Inc's II. Quarter Investments $ 217 Millions CABA's Balance sheet
Cabaletta Bio Inc's II. Quarter Income $ -51 Millions Quarterly CABA's Income Statement
CABA's Income by Division See CABA's Income by Division


CABA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 115 158 238 107 118
Y / Y Investment Growth -27.24 % -33.53 % 121.12 % -8.88 % 7.68 %
Net Income in Millions -168 -116 -68 -53 -46
Y / Y Net Income Growth - - - - -
Annual Return On Investment -146.05 % -73.35 % -28.48 % -49.29 % -39.24 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CABA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CABA's Competitors
Subscribers only: Roi for Cabaletta Bio Inc's Suppliers
Subscribers only: Return On Investment for CABA's Customers

Other Ratios
CABA's Roa CABA's Inventory Turnover Ratio CABA's Growth Rates CABA's Dividend Statistics
CABA's Profitability Ratios CABA's Asset Turnover Ratio CABA's Dividend Growth
CABA's Roe CABA's Valuation Ratios CABA's Financial Strength Ratios CABA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:37:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.